How to Buy Protalix Biotherapeutics Stock
Protalix Biotherapeutics Inc
Protalix BioTherapeutics, Inc. , a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, rest of Latin America, and internationally.
Protalix Biotherapeutics stock last closed at $2.11, up 0.48% from the previous day, and has increased 32.7% in one year. It has overperformed other stocks in the Biotechnology industry by 1.07 percentage points. Protalix Biotherapeutics stock is currently +59.85% from its 52-week low of $1.32, and -33.86% from its 52-week high of $3.19.
At the moment, there are 80.57M PLX shares outstanding. The market value of PLX is $170.01M. In the last 24 hours, 425,000 PLX shares were traded.
How to Buy Protalix Biotherapeutics Stock
Not sure how to invest in Protalix Biotherapeutics stock? Here's how.
- Choose where to buy Protalix Biotherapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Protalix Biotherapeutics stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Pick your payment method and add your info.
- Research Protalix Biotherapeutics stock: The Protalix Biotherapeutics ticker symbol is PLX. Is Protalix Biotherapeutics stock a good investment? Should you buy shares of PLX? How do PLX's underlying business fundamentals look? Do top analysts think Protalix Biotherapeutics is a good buy? Why has PLX's stock price moved recently? (Hint: Our stock research tools can help you decide if PLX is a good stock to buy).
- Place your PLX purchase: Decide if you will purchase PLX shares at the current market price or use a limit order to buy PLX stock at a particular price.
- Track your investment in PLX: Create a watchlist to the latest updates on your new investment in Protalix Biotherapeutics stock.
Step 1: Choose where to buy Protalix Biotherapeutics stock
You will need a brokerage account in order to access the NYSEMKT market and buy PLX stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal details so you can invest in PLX today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create a new brokerage account.
- Send your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have finished signing up on app for stock market, you can securely and quickly fund your account:
Watch this video walkthrough if you need help depositing money into your investment account.
Step 4: Research Protalix Biotherapeutics stock
After you have figured out the best place to buy Protalix Biotherapeutics stock, it's absolutely critical to research their stock prior to investing, so you actually comprehend the risk and upside.
Overview of key PLX info
PLX Due Diligence Checks
WallStreetZen was built to help average investors perform more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on PLX's stock page.
Is PLX stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge PLX's intrinsic value.
Using relative valuations metrics:
- PLX may be undervalued based on its P/E ratio of 11.11x, relative to Biotechnology industry P/E ratio of 15.12x
- PLX could be undervalued based on its P/B ratio of 2.53x, relative to Biotechnology industry P/B ratio of 4.94x
- PLX could be undervalued based on its PEG ratio of 0.96x
You can do more valuation research on PLX's stock here.
How do PLX Financials look?
Passed Financial Due Diligence Checks:
- Total PLX debt is lower than 5 years ago, relative to shareholder equity.
- PLX's operating cash flow of $15.09M allows it to safely service it's debt of $8.48M.
- PLX profit margin has gone up from 6.5% to 20.1% in the past year.
- PLX earnings of $20.80M is not sufficient to cover its interest payments.
- There are more short-term assets than long-term liabilities on the PLX balance sheet.
- There are more short-term assets than short-term liabilities on the PLX balance sheet.
Failed Financial Due Diligence Checks:
- PLX has a relatively high debt to equity ratio of 0.52.
Is PLX stock a Buy, Hold, or Sell, according to analysts?
Out of 1 sell side analysts who track PLX, the consensus analyst rating on PLX is a Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Protalix Biotherapeutics stock forecast page.
PLX Technical Indicators
How are PLX Revenues/Earnings doing?
Last year, PLX earnings were $15.33M. In the past 2 year, PLX's earnings have grown by 37.84% per year. This was faster than the Biotechnology industry average of 11.96%.
Last year, PLX revenue was $76.38M. During the past five year, PLX's revenue has grown by 7.76% per year. This was slower than the Biotechnology industry average of 29.4%.
Dig into PLX's earnings and revenue performance here.
Who is buying/selling PLX?
Over the past year, insiders at PLX have bought more shares than they have sold.
Dror Bashan, PRESIDENT AND CEO of PLX, was the latest PLX insider to buy. They bought $101,360.00 worth of PLX shares on Dec 19, 2025.
Learn more about who owns PLX stock here.
Does PLX stock generate passive income?
No, Protalix Biotherapeutics doesn't provide an income stream by paying out dividends.
PLX Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your PLX purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly sufficient. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount, use a limit order.
Press the Open button and eToro will place the order.
If you need more help with investing in stocks on eToro, watch the helpful video below:
Step 6: Track your investment in PLX
Now that you own some PLX shares, you'll want to keep up with your new company.
Start a watchlist to get the latest updates about your PLX stock.
PLX Feed
How to Buy Stock in Protalix Biotherapeutics
To summarize, here are the 6 steps to buy stock in Protalix Biotherapeutics:
- Choose where to buy Protalix Biotherapeutics stock
- Open a brokerage account
- Deposit money your investment account
- Research Protalix Biotherapeutics stock
- Place your PLX purchase
- Track your investment in PLX
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep an eye on your investment in Protalix Biotherapeutics, add PLX to your watchlist below.
Other Content You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.